Forecast & Rating4 analysts currently cover Cytek Biosciences, of which 2 give a positive rating. The average price target is $5.56, about 5.0% upside from the current price of $5.30. Coverage is limited, so the data is for reference only. Data as of Sep 9, 2026; this does not constitute investment advice.
Sep 9, 2026Price forecast
$5.564.95%
Forecast & RatingBuy
4analysts
- Strong buy25.00%
- Buy25.00%
- Hold50.00%
- Sell0.00%
- Strong sell0.00%
Target price forecast
Forecast dateSep 14, 2026
Forecast met20.2%
Stock price$5.30
Avg. target$5.6
High target$8
Low target$5
Analyst ratings
Strong buy
Buy
Hold
Sell
Strong sell
Source: S&P Global
This information is for reference only and is not investment advice.